Summary
Verisante Technology Inc (Verisante), develops and commercializes products for the early detection of all forms of skin cancer. The company’s key product offerings include Verisante Aura, Verisante Core and Verisante MSI Camera. The Verisante Aura is used for skin cancer detection, and Verisante Core is used for lung, colon and cervical cancer detection. Verisante MSI Camera is a multispectral imaging camera used in the detection of oral and skin cancer. The cancer detection technology helps the company to develop and offer wide range of compact and non-invasive cancer detection devices. The company is ISO 13485:2003 certified as a medical device manufacturer. Verisante is headquartered in Richmond, British Columbia, Canada.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Verisante Technology Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
- Verisante Technology Inc Company Overview 4
- Verisante Technology Inc Company Snapshot 4
- Verisante Technology Inc Pipeline Products and Ongoing Clinical Trials Overview 4
- Verisante Technology Inc – Pipeline Analysis Overview 7
- Business Description 7
- Verisante Technology Inc - Key Facts 7
- Verisante Technology Inc - Major Products and Services 8
- Verisante Technology Inc Pipeline Products by Development Stage 9
- Verisante Technology Inc Pipeline Products Overview 11
- ClearVu 11
- ClearVu Product Overview 11
- ClearVu Elite 12
- ClearVu Elite Product Overview 12
- Multispectral Imaging (MSI) System 13
- Multispectral Imaging (MSI) System Product Overview 13
- Verisante Aura 14
- Verisante Aura Product Overview 14
- Verisante Core - Cervical Cancer 15
- Verisante Core - Cervical Cancer Product Overview 15
- Verisante Core - Gastrointestinal Cancer 16
- Verisante Core - Gastrointestinal Cancer Product Overview 16
- Verisante Core - Lung Cancer 17
- Verisante Core - Lung Cancer Product Overview 17
- Verisante Core - Nasopharnygeal Cancer 18
- Verisante Core - Nasopharnygeal Cancer Product Overview 18
- Verisante Technology Inc - Key Competitors 19
- Verisante Technology Inc - Key Employees 20
- Verisante Technology Inc - Key Employee Biographies 21
- Verisante Technology Inc - Locations And Subsidiaries 22
- Head Office 22
- Recent Developments 23
- Verisante Technology Inc, Recent Developments 23
- Dec 21, 2015: Verisante Provides Operational Update 23
- Jul 03, 2015: Verisante Provides Operational Update 23
- Mar 12, 2015: Verisante Obtains Mexican Approval 24
- Feb 18, 2015: Verisante Technology Announces Equipment Loan to Further Collaboration with Key Chinese Laboratory 24
- Oct 01, 2014: Verisante Technology Announces Submission to the FDA for Aura, a Skin Cancer Detection Device 24
- Jul 29, 2014: Verisante Technology Welcomes Dr. Kenneth Beer and Dr. Philip Werschler onto Clinical Advisory Board 25
- Jun 10, 2014: Verisante Technology Partners with the BC Cancer Foundation to Showcase Aura for Skin Cancer Detection 25
- Jun 02, 2014: Verisante Technology, Inc. Announces 2014 First Quarter Results and Provides Operational Update 26
- May 13, 2014: Verisante Technology Announces Milestone Completion of Core Commercial Prototype for the Detection of Lung Cancer 27
- Apr 30, 2014: Verisante Technology Announces 2013 Year End Results and Strategy for Direct Distribution 28
- Appendix 29
- Methodology 29
- About GlobalData 31
- Contact Us 31
- Disclaimer 32
- List of Tables
- Verisante Technology Inc Pipeline Products and Ongoing Clinical Trials Overview 4
- Verisante Technology Inc Pipeline Products by Equipment Type 5
- Verisante Technology Inc Pipeline Products by Indication 6
- Verisante Technology Inc, Key Facts 7
- Verisante Technology Inc, Major Products and Services 8
- Verisante Technology Inc Number of Pipeline Products by Development Stage 9
- Verisante Technology Inc Pipeline Products Summary by Development Stage 10
- ClearVu - Product Status 11
- ClearVu - Product Description 11
- ClearVu Elite - Product Status 12
- ClearVu Elite - Product Description 12
- Multispectral Imaging (MSI) System - Product Status 13
- Multispectral Imaging (MSI) System - Product Description 13
- Verisante Aura - Product Status 14
- Verisante Aura - Product Description 14
- Verisante Core - Cervical Cancer - Product Status 15
- Verisante Core - Cervical Cancer - Product Description 15
- Verisante Core - Gastrointestinal Cancer - Product Status 16
- Verisante Core - Gastrointestinal Cancer - Product Description 16
- Verisante Core - Lung Cancer - Product Status 17
- Verisante Core - Lung Cancer - Product Description 17
- Verisante Core - Nasopharnygeal Cancer - Product Status 18
- Verisante Core - Nasopharnygeal Cancer - Product Description 18
- Verisante Technology Inc, Key Employees 20
- Verisante Technology Inc, Key Employee Biographies 21
- Glossary 30
- List of Figures
- Verisante Technology Inc Pipeline Products by Equipment Type
- Verisante Technology Inc Pipeline Products by Development Stage